These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20379319)

  • 1. Orbital mass as a presenting sign of acute leukemia.
    Sari A; Erkayhan G; Unal S; Adiguzel U
    Can J Ophthalmol; 2010 Apr; 45(2):188-9. PubMed ID: 20379319
    [No Abstract]   [Full Text] [Related]  

  • 2. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
    Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R
    Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia.
    Bezerra MF; Coelho-Silva JL; Nascimento JC; Benicio MT; Rocha CR; Machado CG; Rego EM; Bezerra MA; Lucena-Araujo AR; Beltrão EI
    Haematologica; 2017 Feb; 102(2):e43-e46. PubMed ID: 27846614
    [No Abstract]   [Full Text] [Related]  

  • 4. Bilateral Acute Proptosis as Initial Manifestation of Acute Myeloid Leukemia.
    Huang YC; Wang SC; Chen SN; Jou JR
    Orbit; 2015; 34(5):248-52. PubMed ID: 26186043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission induction therapy for adults with acute myelogenous leukemia: towards the ICE age?
    Bassan R; Barbui T
    Haematologica; 1995; 80(1):82-90. PubMed ID: 7758997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine, cytarabine, granulocyte colony-stimulating factor, and idarubicin (FLAG-IDA) for the treatment of children with poor-prognosis acute leukemia: the Hacettepe experience.
    Tavil B; Aytac S; Balci YI; Unal S; Kuskonmaz B; Yetgin S; Gurgey A; Tuncer M; Gumruk F; Uckan D; Cetin M
    Pediatr Hematol Oncol; 2010 Oct; 27(7):517-28. PubMed ID: 20677923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia presenting as non-neutropenic colitis in an infant.
    Köhler H; Nurko S; Glickman J; Furuta GT
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):631-3. PubMed ID: 14581811
    [No Abstract]   [Full Text] [Related]  

  • 8. Facts about FCE (fludarabine, cytarabine, etoposide) in acute myeloid leukemia.
    Medeiros BC
    Acta Haematol; 2014; 131(4):200-1. PubMed ID: 24296429
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute myeloid leukemia complicating multiple myeloma: a case successfully treated with etoposide, thioguanine, and cytarabine.
    Erikci AA; Ozturk A; Tekgunduz E; Sayan O
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):E14-5. PubMed ID: 19717372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idarubicin in acute leukemia: results of US trials.
    Berman E; Raymond V; Gee TS; Kempin SJ; Gulati S; Andreeff M; Gabrilove J; Young CW; Clarkson BD; Wiernik PH
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():49. PubMed ID: 2713561
    [No Abstract]   [Full Text] [Related]  

  • 11. [Klinefelter syndrome and acute myeloblastic leukaemia].
    Bellaaj H; Sandi HS; Kammoun H; Kallel C; Kassar O; Elloumi M
    Presse Med; 2009 Jun; 38(6):1019-22. PubMed ID: 19167185
    [No Abstract]   [Full Text] [Related]  

  • 12. Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results.
    Pigneux A; Perreau V; Jourdan E; Vey N; Dastugue N; Huguet F; Sotto JJ; Salmi LR; Ifrah N; Reiffers J
    Haematologica; 2007 Oct; 92(10):1327-34. PubMed ID: 18024370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL).
    Carella AM; Pungolino E; Piatti G; Giordano D; Cerri R; Risso M; Nati S
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():50-1. PubMed ID: 2713562
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment.
    Reinhardt D; Diekamp S; Langebrake C; Ritter J; Stary J; Dworzak M; Schrauder A; Zimmermann M; Fleischhack G; Ludwig WD; Harbott J; Creutzig U
    Leukemia; 2005 Aug; 19(8):1495-6. PubMed ID: 15920489
    [No Abstract]   [Full Text] [Related]  

  • 15. Acceleration of leukaemia with granulocyte colony-stimulating factor in a patient with aleukaemic leukaemia.
    Fata F; Myers P; Addeo J; Nawabi I
    Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):111-2. PubMed ID: 9349378
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
    Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of myeloperoxidase stain in the differential diagnosis of leukemia cutis vs. hystiocitoid Sweet syndrome.
    Valerón-Almazán P; Bastida J; Vilar J; Santana N; Medina C; Carretero G
    Dermatol Online J; 2011 Apr; 17(4):11. PubMed ID: 21549086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blue toes and a new pair of shoes--challenges in diagnosis and treatment of acute myelogenous leukemia.
    Mar N; Gorgan MA; Dailey ME; Vredenburgh JJ
    Am J Hematol; 2013 Dec; 88(12):1090-3. PubMed ID: 23918652
    [No Abstract]   [Full Text] [Related]  

  • 19. Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results.
    Bassan R; Chiodini B; Zucchetti M; Lerede T; Cornelli PE; Cortelazzo S; Barbui T
    Haematologica; 1998 Jan; 83(1):27-33. PubMed ID: 9542320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoplastic mastocytosis evolving from a poor prognosis acute myeloid leukemia].
    Chen-Liang TH; Jerez A; Florensa L; Ortuño FJ
    Med Clin (Barc); 2015 Jun; 144(12):571-2. PubMed ID: 25249393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.